Vanderbilt University Medical Center has received a $7 million, five-year funding award from PCORI (Patient-Centered Outcomes Research Institute) to compare two sedatives used to place breathing tubes in the emergency department (ED) or intensive care unit (ICU).
Signal: Roche to refile subcutaneous Tecentriq with FDA after UK approval – Pharmaceutical Technology
Roche has pushed back the launch of its subcutaneous Tecentriq to 2024. Photo: Qilai Shen/Bloomberg via Getty Images. Pharmaceuticals giant Roche reportedly plans to file